ArticleLeukemia & lymphoma2015

Integrated analysis of CRLF2 signaling in acute lymphoblastic leukemia identifies Polo-like kinase 1 as a potential therapeutic target.

Tai-Chung Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.